Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn

Table of Contents

January 01, 2001; Volume 59,Issue 1

Accelerated Communications

  • You have access
    Identification of Rat H3 Receptor Isoforms with Different Brain Expression and Signaling Properties
    Guillaume Drutel, Nina Peitsaro, Kaj Karlstedt, Kerstin Wieland, Martine J. Smit, Henk Timmerman, Pertti Panula and Rob Leurs
    Molecular Pharmacology January 2001, 59 (1) 1-8; DOI: https://doi.org/10.1124/mol.59.1.1
  • You have access
    Iodo-Resiniferatoxin, a New Potent Vanilloid Receptor Antagonist
    Philip Wahl, Christian Foged, Søren Tullin and Christian Thomsen
    Molecular Pharmacology January 2001, 59 (1) 9-15; DOI: https://doi.org/10.1124/mol.59.1.9

Articles

  • You have access
    Regulation of BKca Channels Expressed in Human Embryonic Kidney 293 Cells by Epoxyeicosatrienoic Acid
    Mitsuhiro Fukao, Helen S. Mason, James L. Kenyon, Burton Horowitz and Kathleen D. Keef
    Molecular Pharmacology January 2001, 59 (1) 16-23; DOI: https://doi.org/10.1124/mol.59.1.16
  • You have access
    Agmatine Enhances the NADPH Oxidase Activity of Neuronal NO Synthase and Leads to Oxidative Inactivation of the Enzyme
    Damon R. Demady, Suree Jianmongkol, Jennifer L. Vuletich, Andrew T. Bender and Yoichi Osawa
    Molecular Pharmacology January 2001, 59 (1) 24-29; DOI: https://doi.org/10.1124/mol.59.1.24
  • You have access
    SCH-202676: An Allosteric Modulator of Both Agonist and Antagonist Binding to G Protein-Coupled Receptors
    Ahmad B. Fawzi, Douglas Macdonald, Lawrence L. Benbow, April Smith-Torhan, Hongtao Zhang, Blair C. Weig, Ginny Ho, Deen Tulshian, Maurine E. Linder and Michael P. Graziano
    Molecular Pharmacology January 2001, 59 (1) 30-37; DOI: https://doi.org/10.1124/mol.59.1.30
  • You have access
    Increased Stability of Nucleophosmin/B23 in Anti-Apoptotic Effect of Ras during Serum Deprivation
    Chih C. Chou and Benjamin Y. M. Yung
    Molecular Pharmacology January 2001, 59 (1) 38-45; DOI: https://doi.org/10.1124/mol.59.1.38
  • You have access
    Covalent and Noncovalent Interactions Mediate Metabotropic Glutamate Receptor mGlu5 Dimerization
    Carmelo Romano, Judith Kelvin Miller, Krzysztof Hyrc, Seta Dikranian, Steven Mennerick, Yutaka Takeuchi, Mark P. Goldberg and Karen L. O'Malley
    Molecular Pharmacology January 2001, 59 (1) 46-53; DOI: https://doi.org/10.1124/mol.59.1.46
  • You have access
    “cAMP-Specific” Phosphodiesterase Contributes to cGMP Degradation in Cerebellar Cells Exposed to Nitric Oxide
    Tomas C. Bellamy and John Garthwaite
    Molecular Pharmacology January 2001, 59 (1) 54-61; DOI: https://doi.org/10.1124/mol.59.1.54
  • You have access
    Competitive and Allosteric Interactions in Ligand Binding to P-glycoprotein as Observed on an Immobilized P-glycoprotein Liquid Chromatographic Stationary Phase
    Lili Lu, Fabio Leonessa, Robert Clarke and Irving W. Wainer
    Molecular Pharmacology January 2001, 59 (1) 62-68; DOI: https://doi.org/10.1124/mol.59.1.62
  • You have access
    Regulation of Bleomycin-Induced DNA Breakage and Chromatin Structure in Lung Endothelial Cells by Integrins and Poly(ADP-Ribose) Polymerase
    Carleton B. Jones, Jane McIntosh, Hong Huang, Andrea Graytock and Dale G. Hoyt
    Molecular Pharmacology January 2001, 59 (1) 69-75; DOI: https://doi.org/10.1124/mol.59.1.69
  • You have access
    A3 Adenosine Receptor Activation Triggers Phosphorylation of Protein Kinase B and Protects Rat Basophilic Leukemia 2H3 Mast Cells from Apoptosis
    Zhenhai Gao, Bing-Sheng Li, Yuan-Ji Day and Joel Linden
    Molecular Pharmacology January 2001, 59 (1) 76-82; DOI: https://doi.org/10.1124/mol.59.1.76
  • You have access
    The Antidepressant-Sensitive Dopamine Transporter inDrosophila melanogaster: A Primordial Carrier for Catecholamines
    Peter Pörzgen, Sang Ki Park, Jay Hirsh, Mark S. Sonders and Susan G. Amara
    Molecular Pharmacology January 2001, 59 (1) 83-95; DOI: https://doi.org/10.1124/mol.59.1.83
  • You have access
    DNA-Interactive Anticancer Aza-Anthrapyrazoles: Biophysical and Biochemical Studies Relevant to the Mechanism of Action
    C. Sissi, S. Moro, S. Richter, B. Gatto, E. Menta, S. Spinelli, A. P. Krapcho, F. Zunino and M. Palumbo
    Molecular Pharmacology January 2001, 59 (1) 96-103; DOI: https://doi.org/10.1124/mol.59.1.96
  • You have access
    The Role of Hydrogen Peroxide in the Contractile Response to Angiotensin II
    Guadalupe Torrecillas, Maria del Carmen Boyano-Adánez, J. Medina, Trinidad Parra, Mercedes Griera, Susana López-Ongil, Eduardo Arilla, Manuel Rodríguez-Puyol and Diego Rodríguez-Puyol
    Molecular Pharmacology January 2001, 59 (1) 104-112; DOI: https://doi.org/10.1124/mol.59.1.104
  • You have access
    Dopamine D2 Receptor Regulation of the Dopamine Transporter Expressed in Xenopus laevis Oocytes Is Voltage-Independent
    R. Dayne Mayfield and Nancy R. Zahniser
    Molecular Pharmacology January 2001, 59 (1) 113-121; DOI: https://doi.org/10.1124/mol.59.1.113
  • You have access
    Interactions of a Series of Fluoroquinolone Antibacterial Drugs with the Human Cardiac K+ Channel HERG
    Jiesheng Kang, Lin Wang, Xiao-Liang Chen, David J. Triggle and David Rampe
    Molecular Pharmacology January 2001, 59 (1) 122-126; DOI: https://doi.org/10.1124/mol.59.1.122
  • You have access
    Adenosine A2B Receptors Behave as an Alternative Anchoring Protein for Cell Surface Adenosine Deaminase in Lymphocytes and Cultured Cells
    C. Herrera, V. Casadó, F. Ciruela, P. Schofield, J. Mallol, C. Lluis and R. Franco
    Molecular Pharmacology January 2001, 59 (1) 127-134; DOI: https://doi.org/10.1124/mol.59.1.127
  • You have access
    MDM2 Mediated Nuclear Exclusion of p53 Attenuates Etoposide-Induced Apoptosis in Neuroblastoma Cells
    Ana M. Rodriguez-Lopez, Dia Xenaki, Tim O. B. Eden, John A. Hickman and Christine M. Chresta
    Molecular Pharmacology January 2001, 59 (1) 135-143; DOI: https://doi.org/10.1124/mol.59.1.135
  • You have access
    γ-Aminobutyric Acid Type B Receptors with Specific Heterodimer Composition and Postsynaptic Actions in Hippocampal Neurons Are Targets of Anticonvulsant Gabapentin Action
    Gordon Y. K. Ng, Sandrine Bertrand, Richard Sullivan, Nathalie Ethier, Jennifer Wang, Jim Yergey, Michel Belley, Laird Trimble, Kevin Bateman, Luanda Alder, Alison Smith, Ruth McKernan, Kathleen Metters, Gary P. O'Neill, Jean-Claude Lacaille and Terence E. Hébert
    Molecular Pharmacology January 2001, 59 (1) 144-152; DOI: https://doi.org/10.1124/mol.59.1.144
  • You have access
    Ethanol Acts Synergistically with a D2 Dopamine Agonist to Cause Translocation of Protein Kinase C
    Adrienne S. Gordon, Lina Yao, Zhan Jiang, C. Simone Fishburn, Sara Fuchs and Ivan Diamond
    Molecular Pharmacology January 2001, 59 (1) 153-160; DOI: https://doi.org/10.1124/mol.59.1.153

Erratum

  • You have access
    Molecular Pharmacology January 2001, 59 (1) 161; DOI: https://doi.org/10.1124/mol.59.1.161
Back to top
PreviousNext

In this issue

Molecular Pharmacology: 59 (1)
Molecular Pharmacology
Vol. 59, Issue 1
1 Jan 2001
  • Table of Contents
  • About the Cover
  • Index by author
Sign up for alerts

Jump to

  • Accelerated Communications
  • Articles
  • Erratum
  • Most Cited
  • Most Read
Loading
  • SB-431542 Is a Potent and Specific Inhibitor of Transforming Growth Factor-β Superfamily Type I Activin Receptor-Like Kinase (ALK) Receptors ALK4, ALK5, and ALK7
  • The G-Protein-Coupled Receptors in the Human Genome Form Five Main Families. Phylogenetic Analysis, Paralogon Groups, and Fingerprints
  • Pharmacological Properties of Y-27632, a Specific Inhibitor of Rho-Associated Kinases
  • Pharmacological characterization of five cloned voltage-gated K+ channels, types Kv1.1, 1.2, 1.3, 1.5, and 3.1, stably expressed in mammalian cell lines.
  • The Orphan Human Pregnane X Receptor Mediates the Transcriptional Activation of CYP3A4 by Rifampicin through a Distal Enhancer Module
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics